Answers are grounded in this paper and cite their sources.
Cervical cancer is a leading cause of cancer-related deaths among Mexican women [75]. Women with type 2 diabetes mellitus are more prone to HPV infections, raising their cervical cancer risk [23]. Despite global guidance for Pap smear screening, coverage is low in this group [30]. This study will assess Pap smear use among women aged 21 to 64 with type 2 diabetes at the HGZC/MF No. 21 clinic in León, Guanajuato, in late 2024. Using random sampling and a cross-sectional design, the study will evaluate sociodemographic and clinical factors through structured interviews, aiming to identify screening coverage gaps and guide early prevention strategies for women with chronic illnesses [33].
No takes yet. Share an insight, caveat, or question.
Franco-Torres et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: